This website uses cookies in order to provide you with the best possible user experience. To agree to our use of cookies, continue browsing as normal. Visit our Cookies Policy to learn more about the cookies we use and for information about how to change your preferences.
This website uses cookies in order to provide you with the best possible user experience. To agree to our use of cookies, continue browsing as normal. Visit our Cookies Policy to learn more about the cookies we use and for information about how to change your preferences.

Manufacturing Chemist Pharma – Propanc signs contract manufacturing agreement with AmatsiQBiologicals

"Australian cancer drug developer Propanc Health Group has signed a contract manufacturing agreement with Belgian firm AmatsiQBiologicals.

AmatsiQBiologicals will develop and manufacture under GMP (Good Manufacturing Practice) some of Propanc's enzymes for development purposes, including for first-in-man studies for the company's lead product, PRP."

Source : Manufacturing Chemist Pharma

Related news

Amatsigroup acquires Q-Biologicals and strengthens its biologicals offer

Amatsigroup acquires Q-Biologicals and strengthens its offering for international pharmaceutical groups Q-Biologicals, a leading-edge provider of process development and biomanufacturing services Amatsigroup strengthens its position in the d…
Read more

Amatsigroup acquires Seps Pharma in Belgium

AMATSIGROUP, the leading French supplier of services devoted to the development of both human and veterinary pharmaceutical products, announces the acquisition of Belgian company SEPS Pharma, which provides drug product development services, encompa…
Read more

Amatsigroup announces the merger of Avogadro, Amatsi, DBI and Avepharm

Montpellier (France), September 17, 2013 – Amatsigroup, an independent services company in the human and veterinary drug development sector, announces the merger of the companies within its perimeter, Avogadro, Amatsi, DBI and Avepharm. This oper…
Read more

CONTACT US

Your message has been sent.

I’m
your name
from
your company,
your region
. I would like to discuss
select a topic
so please call me at
your phone number
or send an e-mail to
your e-mail address
and
leave your message.